Skip to content

Ziphius

Active
Public limited companyfounded 2020active for 6 yearsRijvisschestraat 120, 9052 Gent, BelgiumKBO/BCE: BE 0750.500.975
Summary

The annual accounts of Ziphius for financial year 2025 show a net loss of 124% of total assets and of 94% of the equity at the start of that year. The 2025 annual accounts show equity of €5.9m and a net result of -€11.8m. Equity is shrinking by about 34% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2027. Its solvency ranks better than 75% of 60 sector peers (NACE 21, financial year 2025). The company has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.9% (low).

Risk analysisFollow ReportCompare
ZiphiusActiveChecked score 55/100
Risk analysis ReportCompare

History

On 10 July 2020, Ziphius was incorporated as a public limited company.1 In 2024 the company took the name Ziphius.2 The registered office was moved to Zwijnaarde in 2024.3 The capital was increased 4 times between 2024 and 2026, most recently to €16.9m.456 Total assets went from €26.3m in 2021 to €9.5m in 2025 and headcount from 16.5 to 41.2 full-time equivalents.7

  1. 1KBO register
  2. 2Belgian Official Gazette, 19-04-2024
  3. 3Belgian Official Gazette, 22-10-2024
  4. 4Belgian Official Gazette, 06-05-2024
  5. 5Belgian Official Gazette, 14-07-2025
  6. 6Belgian Official Gazette, 08-06-2026
  7. 7National Bank, annual accounts 2021 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
08-06
Gazette deed Capital & shares
Auditor report · Capital increase · Share issue31 facts ▸
  • General meeting, 28-05-2026
  • Other provision, “kennisneming en bespreking van verslagen, De vergadering neemt kennis van en bespreekt de in agendapunt 1 van de agenda vermelde verslagen, waarvan de aandeelho…” (deed in Dutch)
  • Other provision, “kennisneming bijzonder verslag Raad van Bestuur, De vergadering bevestigt kennis te hebben genomen en akte te nemen van het bijzonder verslag van de Raad van Be…” (deed in Dutch) (2 times)
  • Auditor report, “verslag van de Commissaris, Op basis van onze beoordeling van de financiële en boekhoudkundige gegevens opgenomen in het verslag van het bestuursorgaan is niets…” (deed in Dutch)
  • Other provision, “kennisneming verslag Commissaris, Op basis van onze beoordeling van de financiële en boekhoudkundige gegevens opgenomen in het verslag van het bestuursorgaan is…” (deed in Dutch)
  • General meeting, “kapitaalverhoging door Inbreng in Geld, opheffing van het wettelijk voorkeurrecht” (deed in Dutch)
  • Capital increase, €517,452.30
  • Share issue, 26-05-2026
  • Reserve release, “onbeschikbare rekening 'Uitgiftepremies'” (deed in Dutch)
  • Capital, €16,919,988.10 (2 times)
  • Financial instrument, 10419, “uitgifte” (deed in Dutch)
  • General meeting, “uitgifte van Tweede Tranche Inschrijvingsrechten en bijhorende kapitaalverhoging onder opschortende voorwaarde, opheffing van het wettelijk voorkeurrecht” (deed in Dutch)
  • +19 further facts in this act
26-05
NBB filing Annual accounts filed
financial year 2025 · abbreviated format
11-02
Gazette deed Capital & shares · Amendment of the articles
Capital decrease · Capital · Power of attorney12 facts ▸
  • General meeting, 05-12-2025
  • Other provision, “tussentijdse cijfers d.d. 30-09-2025, kennisname daling nettoactief” (deed in Dutch)
  • Other provision, “kennisname bijzonder verslag, verslag opgemaakt overeenkomstig art. 2:52 en 7:228 WVV” (deed in Dutch)
  • Other provision, “art. 2:52 en 7:228 WVV, goedkeuring maatregelen” (deed in Dutch)
  • Capital decrease, €30,175,388
  • Capital decrease, €1,132,576
  • Amendment of the articles, 5
  • Capital, €16,402,535.80
  • Power of attorney
  • Power of attorney, David Dessers
  • Power of attorney, Bas Stobbelaar
  • Power of attorney, Rutger Duden
2025
31-12
Financial Weakest financial yearnet -€11.8m
Net result drops to -€11.8m, the lowest in the series.
14-07
Gazette deed Capital & shares · Amendment of the articles
Financial instrument · Capital increase · Share issue9 facts ▸
  • Board meeting, 11-06-2025
  • General meeting, 23-02-2024
  • Financial instrument, 14309, “exercise” (deed in Dutch)
  • Capital increase, €5,201,770
  • Share issue, “aandelen op naam”, 14309 (deed in Dutch)
  • Bank account, 5201770, EUR
  • Other provision, “akte verleden voor notaris Pol Vanden Broecke te Ertvelde, alle inschrijvingsrechten uitgeoefend” (deed in Dutch)
  • Amendment of the articles, 5
  • Power of attorney
10-06
NBB filing Annual accounts filed
financial year 2024 · abbreviated format
2024
31-12
Financial Liquidity more than triplescurrent ratio 6.21
Current ratio from 1.90 to 6.21; short-term debt falls from €7.9m to €2.1m.
31-12
Financial Equity above €10mequity €12.5m ▲70.2%
Equity rises from €7.3m to €12.5m.
30-12
Gazette deed Capital & shares · Amendment of the articles
Financial instrument · Capital increase · Share issue8 facts ▸
  • Board meeting, 23-12-2024
  • General meeting, 23-02-2024
  • Financial instrument, “Investeerders”, 14305 (deed in Dutch)
  • Capital increase, €5,199,589
  • Share issue, “op naam”, 14305 (deed in Dutch)
  • Bank account, “bankattest afgeleverd door Belfius Bank”, 5199589 (deed in Dutch)
  • Amendment of the articles, 5
  • Power of attorney
22-10
Gazette deed Permanent representative: Christiaan Cardon
Registered-office move3 facts ▸
  • Board meeting, 01-07-2024
  • Registered-office move, 9052 Zwijnaarde, Rijvisschestraat 120
  • Permanent representative, Christiaan Cardon
21-08
Gazette deed Resignation: RNA Pioneering (director)
Permanent representatives: Christiaan Cardon and Johan Bury · Appointments: SAIGA PHARMA, JoB.Bio.com and Geertrui Vanhove9 facts ▸
  • General meeting, 17-05-2024
  • Director resignation, RNA Pioneering (director)
  • Permanent representative, Christiaan Cardon (2 times)
  • Director appointment, SAIGA PHARMA (director)
  • Director appointment, JoB.Bio.com (director)
  • Permanent representative, Johan Bury
  • Director appointment, Geertrui Vanhove (director)
  • Board meeting, 17-05-2024
  • Director appointment, SAIGA PHARMA (managing director)
27-05
NBB filing Annual accounts filed
financial year 2023 · abbreviated format
Show earlier events
06-05
Gazette deed Capital & shares
Financial instrument · Capital increase · Share issue7 facts ▸
  • General meeting, 23-02-2024
  • Board meeting, 18-04-2024
  • Financial instrument, 14305, “exercise” (deed in Dutch)
  • Capital increase, €5,199,589
  • Share issue, “aandelen op naam”, 14305 (deed in Dutch)
  • Amendment of the articles, 5
  • Power of attorney
19-04
Gazette deed Appointments: PwC Bedrijfsrevisoren BV (statutory auditor) and Margareta Nuytinck (director)
Resignation: Post Verba Verbera NV (director) · Permanent representative: Margareta Nuytinck · Auditor report49 facts ▸
  • Other provision, “reikwijdte beoordelingsopdracht toekomstgerichte informatie en levensvatbaarheid” (deed in Dutch)
  • Auditor report, PwC Bedrijfsrevisoren BV
  • Other provision, “bijzonder verslag raad van bestuur inbreng in natura, voorgestelde inbreng in natura met uitgifte nieuwe aandelen” (deed in Dutch)
  • Auditor report, “omstandig verslag Bedrijfsrevisor, voorgestelde inbreng in natura met uitgifte nieuwe aandelen” (deed in Dutch)
  • Auditor report, “Norm inzake opdracht bedrijfsrevisor inbreng in natura en quasi-inbreng Instituut van de Bedrijfsrevisoren, buitengewone algemene vergadering” (deed in Dutch)
  • Auditor report, “inbreng in natura, artikel 7:197 WVV” (deed in Dutch)
  • Auditor report, “op naam, zelfde aard en rechten als bestaande aandelen op moment uitgifte” (deed in Dutch)
  • Auditor report, “artikel 7:197 en 7:179 WVV” (deed in Dutch)
  • Other provision, “aanvang resoluties, II. Resoluties” (deed in Dutch)
  • Name change, Ziphius
  • Capital increase, €4,960,351.80 (2 times)
  • Other provision, “intekning boeking uitgiftepremie vaststelling verwezenlijking”, EUR (deed in Dutch)
  • +37 further facts in this act
2023
23-05
NBB filing Annual accounts filed
financial year 2022 · abbreviated format
2022
13-06
NBB filing Annual accounts filed
financial year 2021 · abbreviated format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
8 of 14 deeds read
About the unread acts

Of the 14 Belgian Official Gazette deeds we know for this company, 8 have been read. The other 6 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

We would like to set cookies. That happens only with your consent. What we measure